Literature DB >> 1982060

Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts.

M J Cooper1, G M Hutchins, P S Cohen, L J Helman, R J Mennie, M A Israel.   

Abstract

We have examined the hypothesis that nonhematopoietic malignancies may contain cells corresponding to those which occur during the differentiation of tissue precursors. Neuroblastoma, an embryonal tumor of the adrenal medulla, was studied because of its well described ability to differentiate both in vivo and in vitro. We examined the expression of four genes during development of the human adrenal medulla: tyrosine hydroxylase, chromagranin A, pG2, and beta-2-microglobulin. The sequential expression of these genes by adrenal neuroblasts marks successive stages during maturation of the chromaffin lineage. We also observed a population of neuroblasts during adrenal medullary development that did not express any of these four genes, suggestive of adrenal medullary cells differentiating along nonchromaffin lineage(s). We then evaluated 27 neuroblastoma cell lines for the expression of these genes and found that 24 expressed chromaffin markers, with 19 of these mimicking the pattern of gene expression found during development. Three cell lines did not express tyrosine hydroxylase, chromogranin A, or pG2, consistent with either a very undifferentiated neural crest cell or maturation along a nonchromaffin lineage. These data indicate that neuroblastoma tumor cells correspond to adrenal neuroblasts arrested during morphogenesis of the adrenal medulla and raise the possibility that malignant transformation of cells at different stages of tissue maturation may contribute to the diversity that characterizes tumors of solid tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982060

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  20 in total

1.  Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.

Authors:  M J Cooper; G M Hutchins; M A Israel
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

2.  FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression.

Authors:  D Tornehave; C H Jensen; B Teisner; L I Larsson
Journal:  Histochem Cell Biol       Date:  1996-12       Impact factor: 4.304

Review 3.  Children's Oncology Group's 2013 blueprint for research: bone tumors.

Authors:  Richard Gorlick; Katherine Janeway; Stephen Lessnick; R Lor Randall; Neyssa Marina
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

4.  MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development.

Authors:  Goleeta Alam; Hongjuan Cui; Huilin Shi; Liqun Yang; Jane Ding; Ling Mao; William A Maltese; Han-Fei Ding
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 5.  Biology of pediatric peripheral neuroectodermal tumors.

Authors:  C J Thiele
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

6.  Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

Authors:  Y J Bang; F Pirnia; W G Fang; W K Kang; O Sartor; L Whitesell; M J Ha; M Tsokos; M D Sheahan; P Nguyen; W T Niklinski; C E Myers; J B Trepel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

8.  Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.

Authors:  Timothy L Lochmann; Krista M Powell; Jungoh Ham; Konstantinos V Floros; Daniel A R Heisey; Richard I J Kurupi; Marissa L Calbert; Maninderjit S Ghotra; Patricia Greninger; Mikhail Dozmorov; Madhu Gowda; Andrew J Souers; C Patrick Reynolds; Cyril H Benes; Anthony C Faber
Journal:  Sci Transl Med       Date:  2018-05-16       Impact factor: 17.956

9.  Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.

Authors:  G Melino; M Annicchiarico-Petruzzelli; L Piredda; E Candi; V Gentile; P J Davies; M Piacentini
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  The effect on cell growth by Wnt1 RNAi in human neuroblastoma SH-SY5Y cell line.

Authors:  Lihong Zhang; Kai Li; Zhibao Lv; Xianmin Xiao; Jicui Zheng
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.